Pioneering drug for rare kidney disease improves outcome for patients

A pioneering drug for a rare kidney disease prevents organ failure and significantly improves the outcome for patients, new research has confirmed.

Related Keywords

United Kingdom ,Danielle Ellis ,James Palmer ,David Kavanagh ,Chloe Pratt ,Aisling Mcmahon ,Vicky Brocklebank ,Newcastle University ,Kidney Research United Kingdom ,Research Council ,Academic Health Science Centres Ahscs ,National Renal Complement Therapeutics Centre ,Newcastle Health Innovation Partners ,National Institute For Health ,Haemolytic Uraemic Syndrome ,Medical Research Council ,National Institute ,Clinical Excellence ,Tyne Hospitals ,National Medical Director ,Specialised Services ,Newcastle Hospitals ,Academic Health Science Centres ,Kidney ,Kidney Disease ,Flood ,Dialysis ,Eculizumab ,Genes ,Enetic ,Immune System ,Kidney Failure ,Kidney Transplant ,Research ,Yndrome ,Transplant ,